Details for New Drug Application (NDA): 060096
✉ Email this page to a colleague
NDA 060096 describes TETRACYN, which is a drug marketed by Pfipharmecs and Pfizer and is included in four NDAs. Additional details are available on the TETRACYN profile page.
The generic ingredient in TETRACYN is procaine hydrochloride; tetracycline hydrochloride. There are seventeen drug master file entries for this compound. Additional details are available on the procaine hydrochloride; tetracycline hydrochloride profile page.
The generic ingredient in TETRACYN is procaine hydrochloride; tetracycline hydrochloride. There are seventeen drug master file entries for this compound. Additional details are available on the procaine hydrochloride; tetracycline hydrochloride profile page.
Summary for 060096
| Tradename: | TETRACYN |
| Applicant: | Pfizer |
| Ingredient: | tetracycline hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 250MG/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
